Piqray (Alpelisib Tablet) 150mg

Piqray (alpelisib) 150mg tablets are prescribed for certain types of breast cancer in postmenopausal women. This targeted therapy works by inhibiting specific pathways in cancer cells. Always follow healthcare provider guidance when using prescription medications.

Strength

150mg

Manufacturer / TM Owner

Novartis

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Piqray 150mg tablets are used to treat advanced or metastatic breast cancer in postmenopausal women with hormone receptor-positive, HER2-negative tumors. It is typically prescribed when cancer has progressed despite prior hormone therapy. Patients with a specific genetic mutation may benefit from this treatment. This medication is taken orally as part of a broader cancer care plan.

Side Effects

Piqray may help slow the growth of cancer cells by blocking signals that promote tumor progression. Some patients experience improved quality of life when this medication is effective. Common effects include mild to moderate gastrointestinal discomfort or fatigue. Individual responses to treatment vary widely.

Precautions & Warnings

Store Piqray 150mg tablets at room temperature away from moisture and heat. Keep this medication out of reach of children and pets. Inform your healthcare provider about all current medications and health conditions before starting treatment. Regular medical monitoring is essential during therapy.

Avoid Interactions

Piqray may interact with strong CYP3A4 inhibitors or inducers, affecting its effectiveness. Grapefruit products can increase alpelisib levels in the blood, potentially raising side effect risks. Discuss all prescription drugs, over-the-counter items, and supplements with your doctor. Alcohol use should be limited during treatment.

Frequently Asked Questions

Piqray is used to treat advanced or metastatic breast cancer in postmenopausal women with specific tumor characteristics.

Store Piqray tablets at room temperature, away from moisture and heat, and keep them out of reach of children.

Always inform your healthcare provider about all medications you take, as Piqray may interact with certain drugs.

Common effects may include gastrointestinal discomfort or fatigue, but individual responses vary.

Piqray is a targeted therapy, not a traditional chemotherapy, and works differently in the body.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.